These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 20032150)

  • 1. Differentiation of malignant thrombus from bland thrombus of the portal vein in patients with hepatocellular carcinoma: application of diffusion-weighted MR imaging.
    Catalano OA; Choy G; Zhu A; Hahn PF; Sahani DV
    Radiology; 2010 Jan; 254(1):154-62. PubMed ID: 20032150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Limited value of diffusion-weighted MR imaging for differentiating bland from malignant portal venous thrombi.
    Yu JS; Chung JJ; Kim JH; Kim KW
    Radiology; 2010 Aug; 256(2):673-4; author reply 674. PubMed ID: 20656851
    [No Abstract]   [Full Text] [Related]  

  • 3. Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging.
    Kim SY; Lee SS; Byun JH; Park SH; Kim JK; Park B; Kim N; Lee MG
    Radiology; 2010 Jun; 255(3):815-23. PubMed ID: 20501719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of conventional MRI sequences and diffusion-weighted imaging in differentiating malignant from benign portal vein thrombus in cirrhotic patients.
    Sandrasegaran K; Tahir B; Nutakki K; Akisik FM; Bodanapally U; Tann M; Chalasani N
    AJR Am J Roentgenol; 2013 Dec; 201(6):1211-9. PubMed ID: 24261359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid-enhanced MR imaging.
    Motosugi U; Ichikawa T; Sou H; Sano K; Tominaga L; Muhi A; Araki T
    Radiology; 2010 Jul; 256(1):151-8. PubMed ID: 20574092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of diffusion-weighted magnetic resonance imaging in the characterization of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver.
    Xu PJ; Yan FH; Wang JH; Shan Y; Ji Y; Chen CZ
    J Comput Assist Tomogr; 2010 Jul; 34(4):506-12. PubMed ID: 20657216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravoxel incoherent motion diffusion-weighted MR imaging of hepatocellular carcinoma: correlation with enhancement degree and histologic grade.
    Woo S; Lee JM; Yoon JH; Joo I; Han JK; Choi BI
    Radiology; 2014 Mar; 270(3):758-67. PubMed ID: 24475811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis.
    Agnello F; Ronot M; Valla DC; Sinkus R; Van Beers BE; Vilgrain V
    Radiology; 2012 Feb; 262(2):511-9. PubMed ID: 22143926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusion-Weighted MRI of Malignant versus Benign Portal Vein Thrombosis.
    Ahn JH; Yu JS; Cho ES; Chung JJ; Kim JH; Kim KW
    Korean J Radiol; 2016; 17(4):533-40. PubMed ID: 27390544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal masses: characterization with diffusion-weighted MR imaging--a preliminary experience.
    Zhang J; Tehrani YM; Wang L; Ishill NM; Schwartz LH; Hricak H
    Radiology; 2008 May; 247(2):458-64. PubMed ID: 18430878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiation of bland from neoplastic thrombus of the portal vein in patients with hepatocellular carcinoma: application of susceptibility-weighted MR imaging.
    Li C; Hu J; Zhou D; Zhao J; Ma K; Yin X; Wang J
    BMC Cancer; 2014 Aug; 14():590. PubMed ID: 25123782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
    Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
    Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of diffusion-weighted with T2-weighted Imaging for detection of small hepatocellular carcinoma in cirrhosis: preliminary quantitative study at 3-T.
    Wang H; Wang XY; Jiang XX; Ye ZX
    Acad Radiol; 2010 Feb; 17(2):239-43. PubMed ID: 19962912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of malignant from benign pheochromocytomas with diffusion-weighted and dynamic contrast-enhanced magnetic resonance at 3.0 T.
    Dong Y; Liu Q
    J Comput Assist Tomogr; 2012; 36(4):361-6. PubMed ID: 22805661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indeterminate orbital masses: restricted diffusion at MR imaging with echo-planar diffusion-weighted imaging predicts malignancy.
    Sepahdari AR; Aakalu VK; Setabutr P; Shiehmorteza M; Naheedy JH; Mafee MF
    Radiology; 2010 Aug; 256(2):554-64. PubMed ID: 20656840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell carcinoma: diffusion-weighted MR imaging for subtype differentiation at 3.0 T.
    Wang H; Cheng L; Zhang X; Wang D; Guo A; Gao Y; Ye H
    Radiology; 2010 Oct; 257(1):135-43. PubMed ID: 20713607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging.
    Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM
    Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffusion-weighted MR imaging with a single-shot echoplanar sequence: detection and characterization of focal hepatic lesions.
    Ichikawa T; Haradome H; Hachiya J; Nitatori T; Araki T
    AJR Am J Roentgenol; 1998 Feb; 170(2):397-402. PubMed ID: 9456953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of Portal Vein Thrombosis (Neoplastic Versus Bland) on CT Images Using Software-Based Texture Analysis and Thrombus Density (Hounsfield Units).
    Canellas R; Mehrkhani F; Patino M; Kambadakone A; Sahani D
    AJR Am J Roentgenol; 2016 Nov; 207(5):W81-W87. PubMed ID: 27490095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of functional MR imaging in the assessment of tumor response after chemoembolization in patients with hepatocellular carcinoma.
    Kamel IR; Bluemke DA; Eng J; Liapi E; Messersmith W; Reyes DK; Geschwind JF
    J Vasc Interv Radiol; 2006 Mar; 17(3):505-12. PubMed ID: 16567675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.